SoPRano Label-free assay technology wins award
PharmaDiagnostics\' label-free screening technology does not require specialised equipment
PharmaDiagnostics BV, a Brussel’s-based company developing, label-free screening technology that does not require specialised equipment, has won the ELRIG Technology Prize at Drug Discovery 2010 Coventry.
The company also won first prize at ELRIG’s Liquid Handling & Label Free Technologies show held in the UK earlier this year for the technology platform called SoPRano.
ELRIG (European Laboratory Robotics Interest Group) is a not for profit organisation that provides a communication forum for users and vendors within the scientific research, development or production community (industrial and academic) with the aim of increasing their awareness of automation techniques.
Label-free screening is an area of great interest and potential growth in pharmaceutical research. To date, the expanding SPR segment of this market has been dominated by providers of expensive specialist instrumentation that is unable, due to technical constraints, to provide the through-put required for routine adoption of label-free screening.
PharmaDiagnostics’ SoPRano label-free platform is the first SPR-based system to utilise standard plate-readers, and simple assay protocols. This makes for increased accessibility for researchers, lowers barrier to adoption and also offers excellent scalability, thus lowering costs, as it is not necessary to increase instrument expenditure to increase throughput.
PharmaDiagnostics’ novel technology platform, SoPRano, is based on localised surface plasmon resonance (LSPR) and noble metal nanoparticles, and is run on standard laboratory equipment.
